Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts K. Sandy PangMichael WeissPanos Macheras OriginalPaper Article: 30
Appropriate calibration curve fitting in ligand binding assays John W. A. FindlayRobert F. Dillard OriginalPaper Article: 29
O-phospho-L-serine, multi-functional excipient for B domain deleted recombinant factor VIII Razvan D. MicleaVivek S. PurohitSathy V. Balu-Iyer OriginalPaper Article: 28
Biodegradable intraprostatic doxorubicin implants Ronnie OrtizJessie L-S. AuM. Guillaume Wientjes OriginalPaper Article: 27
Varying polymer architecture to deliver drugs Felicity HeathPrinal HariaCameron Alexander OriginalPaper Article: 26
Reproductible production of a PEGylated dual-acting peptide for diabetes Irene TomVivian LeeClark Q. Pan OriginalPaper Article: 25
2007 highlights of advances in the pharmaceutical sciences: An American Association of Pharmaceutical Scientists (AAPS) perspective Marilyn N. MartinezPeter BonateManuel Zahn OriginalPaper Article: 24
Population pharmacokinetics of S(−)-carvedilol in healthy volunteers after administration of the immediate-release (IR) and the new controlled-release (CR) dosage forms of the racemate Ahmed A. OthmanDavid M. TeneroMichael J. Fossler OriginalPaper Article: 23
Polymer-drug conjugates as modulators of cellular apoptosis Maria J. Vicent OriginalPaper Article: 22
Characterization of a cyclosporine solid dispersion for inhalation Gerrit S. ZijlstraMichiel RijkeboerHenderik W. Frijlink OriginalPaper Article: 21
Partial derivative—Based sensitivity analysis of models describing target-mediated drug disposition Anson K. AbrahamWojciech KrzyzanskiDonald E. Mager OriginalPaper Article: 20
Nanosystems for simultaneous imaging and drug delivery to T cells Tarke M. FahmyPeter M. FongW. Mark Saltzman OriginalPaper Article: 19
Specificity and selectivity evaluations of ligand binding assay of protein therapeutics against concomitant drugs and related endogenous proteins Jean LeeHongjin Ma OriginalPaper Article: 18
Key elements of bioanalytical method validation for macromolecules Marian KelleyBinodh DeSilva OriginalPaper Article: 17
Critical ligand binding reagent preparation/selection: When specificity depends on reagents Bonita RupDenise O'Hara OriginalPaper Article: 16
Targeted pharmaceutical nanocarriers for cancer therapy and imaging Vladimir P. Torchilin OriginalPaper Article: 15
Procedural elements involved in maintaining bioanalytical data integrity for good laboratory practices studies and regulated clinical studies Christopher A. JamesHoward M. Hill OriginalPaper Article: 14
Best practices during bioanalytical method validation for the characterization of assay reagents and the evaluation of analyte stability in assay standards, quality controls, and study samples William NowatzkeEric Woolf OriginalPaper Article: 13
Brain natriuretic peptide: Potential adjunct for cardiac risk assessment and management during treatment with experimental anticancer agents Mary L. VarterasianMark B. MeyerPatricia M. LoRusso BriefCommunication Article: 12